Pitavastatin-loaded procyanidins self-assembled nanoparticles alleviate advanced atherosclerosis via modulating macrophage efferocytosis and cholesterol efflux
Related Experiment Video
Updated: Sep 15, 2025

Synthesis of Monocyte-targeting Peptide Amphiphile Micelles for Imaging of Atherosclerosis
Published on: November 17, 2017
Yizhou Wu1, Hongyan Zhou2, Hao Liu3
1College of Biology, Hunan University, Changsha 410082, China.
Abstract:
Advanced atherosclerosis is the major global cause of death, as featured by the aggregation of apoptotic cells (ACs) in necrotic cores. The defective efferocytosis and dysfunctional cholesterol efflux of macrophages are the main reasons for forming necrotic cores in advanced atherosclerosis. In this study, we constructed self-assembled procyanidins (PC) NPs for loading pitavastatin (Pita). The designed HA@PC@Pita NPs with hyaluronic acid (HA) modification combined the advantages of efferocytosis restoration of Pita and cholesterol efflux enhancement of PC. In vitro assay indicated that HA@PC@Pita NPs could induce M1/M2 repolarization and upregulate ERK5/Mertk expression to restore efferocytosis of macrophages. Simultaneously, HA@PC@Pita NPs notably promoted cholesterol efflux by promoting macrophage lipophagy, a selective autophagy of lipid droplets. In vivo study showed that HA@PC@Pita NPs cleared necrotic core and enhanced plaque stability in the ApoE -/- mice model with advanced atherosclerosis. Taken together, this study demonstrated the potential of HA@PC@Pita NPs for the treatment of advanced atherosclerosis.
Insights
This study developed hyaluronic acid-modified procyanidin nanoparticles loaded with pitavastatin (HA@PC@Pita NPs) to treat advanced atherosclerosis by restoring macrophage efferocytosis and enhancing cholesterol efflux.
Area of Science:
- Biomedical Engineering
- Cardiovascular Research
- Nanomedicine
Background:
- Advanced atherosclerosis, a leading cause of death, involves apoptotic cell accumulation in necrotic cores.
- Defective efferocytosis and cholesterol efflux in macrophages drive necrotic core formation in atherosclerosis.
Purpose of the Study:
- To develop self-assembled procyanidin nanoparticles (PC NPs) loaded with pitavastatin (Pita) for treating advanced atherosclerosis.
- To investigate the efficacy of hyaluronic acid-modified nanoparticles (HA@PC@Pita NPs) in restoring macrophage efferocytosis and cholesterol efflux.
Main Methods:
- Constructed HA@PC@Pita NPs combining pitavastatin's efferocytosis restoration with procyanidins' cholesterol efflux enhancement.
- Utilized in vitro assays to assess macrophage repolarization, ERK5/Mertk expression, and lipophagy.
- Employed an ApoE-/- mice model to evaluate in vivo plaque stability and necrotic core clearance.
Main Results:
- HA@PC@Pita NPs induced M1/M2 repolarization and upregulated ERK5/Mertk, restoring macrophage efferocytosis.
- Nanoparticles significantly promoted cholesterol efflux via enhanced macrophage lipophagy.
- In vivo studies demonstrated necrotic core clearance and improved plaque stability in a mouse model of advanced atherosclerosis.
Conclusions:
- HA@PC@Pita NPs show potential for treating advanced atherosclerosis by addressing key pathological mechanisms.
- The developed nanomedicine effectively restores macrophage function and enhances plaque stability.
Related Concept Videos
Atherosclerosis III: Management
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Inflammation
Cholesterol: Significance and Regulation
Considering cholesterol and...
Receptor-mediated Endocytosis
Atherosclerosis I: Introduction

